Ad is loading...
ADPT
Price
$5.94
Change
-$0.00 (-0.00%)
Updated
Nov 29 closing price
78 days until earnings call
DNA
Price
$8.70
Change
-$0.00 (-0.00%)
Updated
Nov 29 closing price
Ad is loading...

ADPT vs DNA

Header iconADPT vs DNA Comparison
Open Charts ADPT vs DNABanner chart's image
Adaptive Biotechnologies
Price$5.94
Change-$0.00 (-0.00%)
Volume$660.53K
CapitalizationN/A
Ginkgo Bioworks Holdings
Price$8.70
Change-$0.00 (-0.00%)
Volume$549.03K
CapitalizationN/A
ADPT vs DNA Comparison Chart
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ADPT vs. DNA commentary
Dec 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and DNA is a Hold.

COMPARISON
Comparison
Dec 03, 2024
Stock price -- (ADPT: $5.94 vs. DNA: $8.70)
Brand notoriety: ADPT: Notable vs. DNA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 52% vs. DNA: 54%
Market capitalization -- ADPT: $876.62M vs. DNA: $552.37M
ADPT [@Biotechnology] is valued at $876.62M. DNA’s [@Biotechnology] market capitalization is $552.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileDNA’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • DNA’s FA Score: 1 green, 4 red.
According to our system of comparison, ADPT is a better buy in the long-term than DNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 5 TA indicator(s) are bullish while DNA’s TA Score has 6 bullish TA indicator(s).

  • ADPT’s TA Score: 5 bullish, 5 bearish.
  • DNA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, DNA is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Biotechnology) experienced а +26.65% price change this week, while DNA (@Biotechnology) price change was +21.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.48%. For the same industry, the average monthly price growth was +2.46%, and the average quarterly price growth was +11.09%.

Reported Earning Dates

ADPT is expected to report earnings on Feb 18, 2025.

DNA is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+4.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($877M) has a higher market cap than DNA($552M). ADPT YTD gains are higher at: 21.224 vs. DNA (-87.130). ADPT has higher annual earnings (EBITDA): -163.5M vs. DNA (-630.64M). DNA has more cash in the bank: 616M vs. ADPT (243M). ADPT has less debt than DNA: ADPT (91.8M) vs DNA (446M). DNA has higher revenues than ADPT: DNA (217M) vs ADPT (177M).
ADPTDNAADPT / DNA
Capitalization877M552M159%
EBITDA-163.5M-630.64M26%
Gain YTD21.224-87.130-24%
P/E RatioN/AN/A-
Revenue177M217M82%
Total Cash243M616M39%
Total Debt91.8M446M21%
TECHNICAL ANALYSIS
Technical Analysis
ADPTDNA
RSI
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMEAX17.860.23
+1.30%
Franklin International Equity A
PAGHX101.701.01
+1.00%
Permanent Portfolio Aggressive Growth C
BGIVX14.590.08
+0.57%
Baillie Gifford International Alpha 5
PBLAX47.540.21
+0.44%
Principal Blue Chip A
EAEAX37.670.14
+0.37%
Eaton Vance Tax-Managed Eq Aset Allc A

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+3.66%
AXON - ADPT
56%
Loosely correlated
+1.89%
TECH - ADPT
54%
Loosely correlated
-0.03%
VCYT - ADPT
54%
Loosely correlated
+0.14%
BEAM - ADPT
54%
Loosely correlated
+0.63%
ABCL - ADPT
53%
Loosely correlated
+0.33%
More